Resveratrol-induced autophagy in human U373 glioma cells

Midori Yamamoto, Satoshi Suzuki, Masaru Himeno

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Autophagy is an intracellular protein transport process leading to the degradation of organelles and long-lived proteins in eukaryotes. The down-regulation of autophagy observed in cancer cells has been associated with tumor progression. This study investigated autophagy induced by resveratrol, a natural compound, in human glioma cells. Glioma cells were exposed to resveratrol, and the cell growth and autophagic level were evaluated. Resveratrol inhibited growth and induced cell death in U373 glioma cells. When treated with resveratrol, glioma cells stably expressing GFP fused to LC3, recruited more GFP-LC3-labeled autophagosomes, and the percentage of cells with GFP-LC3-labeled autophagosomes increased. Furthermore, in resveratrol-treated glioma cells, pretreatment with P38 or ERK1/2 inhibitors reduced the autophagic level, suggesting that resveratrol-induced autophagy was positively regulated by P38 and the ERK1/2 pathway. The Akt/mTOR pathway was not involved in resveratrol-induced autophagy. Our results suggest that resveratrol has an anticancer effect on glioma cells by inducing autophagy.

Original languageEnglish
Pages (from-to)489-493
Number of pages5
JournalOncology Letters
Volume1
Issue number3
DOIs
Publication statusPublished - May 1 2010

Fingerprint

Autophagy
Glioma
resveratrol
MAP Kinase Signaling System
Protein Transport
Growth
Eukaryota
Organelles
Neoplasms
Cell Death
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Resveratrol-induced autophagy in human U373 glioma cells. / Yamamoto, Midori; Suzuki, Satoshi; Himeno, Masaru.

In: Oncology Letters, Vol. 1, No. 3, 01.05.2010, p. 489-493.

Research output: Contribution to journalArticle

Yamamoto, Midori ; Suzuki, Satoshi ; Himeno, Masaru. / Resveratrol-induced autophagy in human U373 glioma cells. In: Oncology Letters. 2010 ; Vol. 1, No. 3. pp. 489-493.
@article{0c3e15802da94c9193180a74a0bbb938,
title = "Resveratrol-induced autophagy in human U373 glioma cells",
abstract = "Autophagy is an intracellular protein transport process leading to the degradation of organelles and long-lived proteins in eukaryotes. The down-regulation of autophagy observed in cancer cells has been associated with tumor progression. This study investigated autophagy induced by resveratrol, a natural compound, in human glioma cells. Glioma cells were exposed to resveratrol, and the cell growth and autophagic level were evaluated. Resveratrol inhibited growth and induced cell death in U373 glioma cells. When treated with resveratrol, glioma cells stably expressing GFP fused to LC3, recruited more GFP-LC3-labeled autophagosomes, and the percentage of cells with GFP-LC3-labeled autophagosomes increased. Furthermore, in resveratrol-treated glioma cells, pretreatment with P38 or ERK1/2 inhibitors reduced the autophagic level, suggesting that resveratrol-induced autophagy was positively regulated by P38 and the ERK1/2 pathway. The Akt/mTOR pathway was not involved in resveratrol-induced autophagy. Our results suggest that resveratrol has an anticancer effect on glioma cells by inducing autophagy.",
author = "Midori Yamamoto and Satoshi Suzuki and Masaru Himeno",
year = "2010",
month = "5",
day = "1",
doi = "10.3892/ol_00000086",
language = "English",
volume = "1",
pages = "489--493",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - Resveratrol-induced autophagy in human U373 glioma cells

AU - Yamamoto, Midori

AU - Suzuki, Satoshi

AU - Himeno, Masaru

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Autophagy is an intracellular protein transport process leading to the degradation of organelles and long-lived proteins in eukaryotes. The down-regulation of autophagy observed in cancer cells has been associated with tumor progression. This study investigated autophagy induced by resveratrol, a natural compound, in human glioma cells. Glioma cells were exposed to resveratrol, and the cell growth and autophagic level were evaluated. Resveratrol inhibited growth and induced cell death in U373 glioma cells. When treated with resveratrol, glioma cells stably expressing GFP fused to LC3, recruited more GFP-LC3-labeled autophagosomes, and the percentage of cells with GFP-LC3-labeled autophagosomes increased. Furthermore, in resveratrol-treated glioma cells, pretreatment with P38 or ERK1/2 inhibitors reduced the autophagic level, suggesting that resveratrol-induced autophagy was positively regulated by P38 and the ERK1/2 pathway. The Akt/mTOR pathway was not involved in resveratrol-induced autophagy. Our results suggest that resveratrol has an anticancer effect on glioma cells by inducing autophagy.

AB - Autophagy is an intracellular protein transport process leading to the degradation of organelles and long-lived proteins in eukaryotes. The down-regulation of autophagy observed in cancer cells has been associated with tumor progression. This study investigated autophagy induced by resveratrol, a natural compound, in human glioma cells. Glioma cells were exposed to resveratrol, and the cell growth and autophagic level were evaluated. Resveratrol inhibited growth and induced cell death in U373 glioma cells. When treated with resveratrol, glioma cells stably expressing GFP fused to LC3, recruited more GFP-LC3-labeled autophagosomes, and the percentage of cells with GFP-LC3-labeled autophagosomes increased. Furthermore, in resveratrol-treated glioma cells, pretreatment with P38 or ERK1/2 inhibitors reduced the autophagic level, suggesting that resveratrol-induced autophagy was positively regulated by P38 and the ERK1/2 pathway. The Akt/mTOR pathway was not involved in resveratrol-induced autophagy. Our results suggest that resveratrol has an anticancer effect on glioma cells by inducing autophagy.

UR - http://www.scopus.com/inward/record.url?scp=77955743270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955743270&partnerID=8YFLogxK

U2 - 10.3892/ol_00000086

DO - 10.3892/ol_00000086

M3 - Article

AN - SCOPUS:77955743270

VL - 1

SP - 489

EP - 493

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 3

ER -